Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about Akums Lifesciences aggregated by PharmaCompass.com.

    Client Virtual Booth

    AKUMS LIFESCIENCES

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Akums Lifesciences
    india-flag Flag
    Country
    Country
    India
    Address
    Address
    301, Laxmi Tower-II, LSC Block-C, Saraswati Vihar, New Delhi – 110 034
    Telephone
    Telephone
    +91-8755507983
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://akumslifesciences.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/akums-lifesciences-limited/
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Akums to empower mothers with Doxylamine + Pyridoxine extended-release tablets
    Akums to empower mothers with Doxylamine + Pyridoxine extended-release tablets

    https://www.indianpharmapost.com/news/akums-to-empower-mothers-with-doxylamine-pyridoxine-extended-release-tablets-for-severe-morning-sickness-15073

    INDIAN PHARMA POST
    28 Dec 2023
    Share Share
    Akums, Lyrus Life Sciences collaborate for patented technologies and formulations
    Akums, Lyrus Life Sciences collaborate for patented technologies and formulations

    https://health.economictimes.indiatimes.com/news/pharma/akums-lyrus-life-sciences-collaborate-for-patented-technologies-and-formulations/98148284

    ECONOMIC-TIMES
    22 Feb 2023
    Share Share
    Akums receives DCGI approval for type 2 diabetes drug to improve insulin resistance
    Akums receives DCGI approval for type 2 diabetes drug to improve insulin resistance

    https://www.biospectrumindia.com/news/73/22593/akums-receives-dcgi-approval-for-type-2-diabetes-drug-to-improve-insulin-resistance.html

    BIOSPECTRUM ASIA
    06 Feb 2023
    Share Share
    Akums chalks out expansion plan as it eyes Rs 10K cr turnover by 2028
    Akums chalks out expansion plan as it eyes Rs 10K cr turnover by 2028

    https://health.economictimes.indiatimes.com/news/pharma/akums-chalks-out-expansion-plan-as-it-eyes-rs-10k-cr-turnover-by-2028/95803284

    HEALTH ET
    27 Nov 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search